96 related articles for article (PubMed ID: 9926236)
21. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
23. The distinction of Hodgkin's disease from B cell lymphoma.
Warnke RA
Semin Diagn Pathol; 1992 Nov; 9(4):284-90. PubMed ID: 1480850
[TBL] [Abstract][Full Text] [Related]
24. Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's disease.
Tefferi A; Zellers RA; Banks PM; Therneau TM; Colgan JP
J Clin Oncol; 1990 Dec; 8(12):1959-65. PubMed ID: 2230888
[TBL] [Abstract][Full Text] [Related]
25. Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of Florida.
Chera BS; Olivier K; Morris CG; Lynch JW; Mendenhall NP
Am J Clin Oncol; 2007 Dec; 30(6):601-6. PubMed ID: 18091054
[TBL] [Abstract][Full Text] [Related]
26. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors.
von Wasielewski R; Seth S; Franklin J; Fischer R; Hübner K; Hansmann ML; Diehl V; Georgii A
Blood; 2000 Feb; 95(4):1207-13. PubMed ID: 10666192
[TBL] [Abstract][Full Text] [Related]
27. A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease.
Borg-Grech A; Radford JA; Crowther D; Swindell R; Harris M
J Clin Oncol; 1989 Sep; 7(9):1303-9. PubMed ID: 2769329
[TBL] [Abstract][Full Text] [Related]
28. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Al-Ali HK; Wittekind C; Niederwieser D
Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
[TBL] [Abstract][Full Text] [Related]
29. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease.
Regula DP; Hoppe RT; Weiss LM
N Engl J Med; 1988 Jan; 318(4):214-9. PubMed ID: 3336412
[TBL] [Abstract][Full Text] [Related]
30. Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.
Marafioti T; Mancini C; Ascani S; Sabattini E; Zinzani PL; Pozzobon M; Pulford K; Falini B; Jaffe ES; Müller-Hermelink HK; Mason DY; Pileri SA
Haematologica; 2004 Aug; 89(8):957-64. PubMed ID: 15339679
[TBL] [Abstract][Full Text] [Related]
31. [Nodular lymphocyte-predominant Hodgkin lymphoma in children: clinical course, biology, and management].
Gorde-Grosjean S; Guimard G; Lambilliotte A; Coulomb-Lhermine A; Montravers F; Landman-Parker J
Bull Cancer; 2014 Sep; 101(9):881-90. PubMed ID: 25296072
[TBL] [Abstract][Full Text] [Related]
32. Lymphocyte predominance Hodgkin's disease. A clinicopathologic reassessment.
Trudel MA; Krikorian JG; Neiman RS
Cancer; 1987 Jan; 59(1):99-106. PubMed ID: 3791150
[TBL] [Abstract][Full Text] [Related]
33. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous nodular lymphocyte predominance Hodgkin's disease (N-LPHD) and large-cell lymphoma (LCL).
Whittaker M; Fomcar K; Keith T; McAneny B
Am J Surg Pathol; 1989 Aug; 13(8):715-6. PubMed ID: 2787607
[No Abstract] [Full Text] [Related]
35. Lymphocyte predominant Hodgkin's disease: a clinicopathologic comparative study of histologic and immunophenotypic subtypes.
Crennan E; D'Costa I; Liew KH; Thompson J; Laidlaw C; Cooper I; Quong G
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):333-7. PubMed ID: 7530700
[TBL] [Abstract][Full Text] [Related]
36. T-cell rich B-cell lymphoma: clinical distinctiveness and response to treatment in 45 patients.
Ripp JA; Loiue DC; Chan W; Nawaz H; Portlock CS
Leuk Lymphoma; 2002 Aug; 43(8):1573-80. PubMed ID: 12400599
[TBL] [Abstract][Full Text] [Related]
37. Nodular lymphocyte predominant Hodgkin's lymphoma.
Siddiqui N; Al-Diab AI
Saudi Med J; 2005 Feb; 26(2):241-5. PubMed ID: 15770298
[TBL] [Abstract][Full Text] [Related]
38. Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials.
von Tresckow B; Kreissl S; Goergen H; Bröckelmann PJ; Pabst T; Fridrik M; Rummel M; Jung W; Thiemer J; Sasse S; Bürkle C; Baues C; Diehl V; Engert A; Borchmann P;
Lancet Haematol; 2018 Oct; 5(10):e462-e473. PubMed ID: 30290903
[TBL] [Abstract][Full Text] [Related]
39. [Clinico-pathologic studies of 95 cases of Hodgkin's disease].
Wang QL
Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):385-8. PubMed ID: 1782853
[TBL] [Abstract][Full Text] [Related]
40. Modern management of lymphocyte-predominant Hodgkin lymphoma.
Xing KH; Savage KJ
Br J Haematol; 2013 May; 161(3):316-29. PubMed ID: 23398605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
